Search for stock quotes, financial statistics and more
Paradigm Capital analyst Scott McAuley said in an Aug. 25 note that Spectral Medical (Spectral Medic... Read More
Paradigm Capital analyst Scott McAuley is maintaining a “Buy” rating and $2.30 target on... Read More
Paradigm Capital analyst Scott McAuley likes what he sees in clinical stage medical device company S... Read More
Paradigm Capital analyst Scott McAuley shaved a bit off his target price for Spectral Medical (Spect... Read More
The prospects are still good for clinical-stage medical device company Spectral Medical (Spectral Me... Read More
Share
Tweet
pin
Share